FAQ Category: General

What is HSDD?

That’s the abbreviation for hypoactive sexual desire disorder. It’s a common, treatable medical condition characterized by ongoing low sexual desire that women find frustrating (“hypoactive” means “low”). If you’re diagnosed with “acquired, generalized” HSDD, it means you haven’t had low sexual desire in the past, but you now have low sexual desire no matter the …

What is HSDD? Read More »

What’s Vyleesi?

Vyleesi (bremelanotide injection) is the first and only FDA-approved as-needed treatment for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). It was approved by the FDA on June 21, 2019. Do not use if you have: high blood pressure that is not controlled (uncontrolled hypertension) known heart (cardiovascular) disease See clinical trials info.

Important Safety Information

Do not use Vyleesi if you have:
  • high blood pressure that is not controlled (uncontrolled hypertension)

Book Virtual Appointment

with a healthcare provider now.

Important Safety Information

Do not use Vyleesi if you have:
  • high blood pressure that is not controlled (uncontrolled hypertension)
  • known heart (cardiovascular) disease
Before using Vyleesi, tell your healthcare provider about all of your medical conditions, including if you:
  • have high blood pressure.
  • have heart problems.
  • have kidney problems.
  • have liver problems.
  • are pregnant or plan to become pregnant. It is not known if Vyleesi will harm your unborn baby.
    • Women who can become pregnant should use effective birth control during treatment with Vyleesi.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Vyleesi may affect the way other medicines work, and other medicines may affect the way Vyleesi works.

How should I use Vyleesi?
  • Inject Vyleesi at least 45 minutes before you think that you will begin sexual activity.
  • Do not inject more than 1 dose of Vyleesi within 24 hours of your last dose.
  • Do not inject more than 8 doses of Vyleesi within a month.
What are the possible side effects of Vyleesi? Vyleesi can cause serious side effects, including:
  • Temporary increase in blood pressure and decrease in heart rate: An increase in blood pressure and decrease in heart rate can happen shortly after you inject Vyleesi. These changes usually go away within 12 hours after your injection. Increases in blood pressure and an increased risk of heart (cardiovascular) problems can happen if you use Vyleesi more often than prescribed by your healthcare provider.
  • Darkening of the skin on certain parts of the body (focal hyperpigmentation), including the face, gums (gingiva), and breast. The chance of darkening of the skin is increased in people with darker skin color. The chance of darkening of the skin is higher if Vyleesi is used every day. Darkening of the skin may not go away, even after you stop using Vyleesi.
  • Nausea. Nausea is common and can also be severe. Nausea most commonly happens after the first Vyleesi injection but can also happen after any dose of Vyleesi. The nausea usually lasts for about 2 hours but can last longer in some people. The nausea usually goes away by itself. Tell your healthcare provider if you have nausea that is severe or does not go away.

The most common side effects of Vyleesi include: flushing, injection site reactions, headache, vomiting, cough, fatigue, hot flush, tingling, dizziness, and nasal congestion. These are not all the possible side effects of Vyleesi.

Call your doctor for medical advice about side effects. To report SUSPECTED ADVERSE REACTIONS, contact Palatin Technologies at 1-800-972-5220 or FDA at 1-800-FDA-1088 or fda.gov/medwatch.

INDICATION What is Vyleesi?

Vyleesi is a prescription medicine used to treat hypoactive (low) sexual desire disorder (HSDD) in women who have not gone through menopause, who have not had problems with low sexual desire in the past, and who have low sexual desire no matter the type of sexual activity, the situation, or the sexual partner. Women with HSDD have low sexual desire that is troubling to them. Their low sexual desire is not due to:

  • a medical or mental health problem
  • problems in the relationship
  • medicine or other drug use

Vyleesi is not for the treatment of HSDD in women who have gone through menopause or in men.

Vyleesi is not for use to improve sexual performance.

Vyleesi is not for use in children.

Palatin Logo

Follow us:

Facebook-f Instagram Icon

#vyleesi, #hsddtreatment

Palatin Logo
© 2022 Palatin Technologies, Inc.

Vyleesi is a registered trademark of Palatin Technologies, Inc.
All trademarks and registered trademarks are property of their respective owners.
Distributed by Palatin Technologies, Inc.
4-B Cedar Brook Drive, Cedar Brook Corporate Center, Cranbury, NJ 08512

All Rights Reserved   |  PP-VLS-US-00204-8 8/22

Terms & Conditions

*Depending on your insurance coverage, most eligible patients may pay as little as $0. Each patient’s eligibility is evaluated on an individual basis. Patients must be 18 or older to qualify. These programs and any assistance provided may be discontinued or modified at any time based on eligibility, state and local laws, and program availability. Patients insured by a government-funded program (Medicaid, TRICARE, etc.) are not eligible.

Financial assistance applies to the patient’s copay, coinsurance, or deductible for patients receiving Vyleesi. Palatin contributions against patient deductible and/or out-of-pocket maximums are subject to possible health plan restrictions. Palatin copay assistance will only apply to 2 fills every 30 days. Enrollment into the program cannot be retroactive.

Get a diagnosis

If your healthcare provider suspects that you may have HSDD, he or she will likely ask you 5 questions from the Decreased Sexual Desire Screener (DSDS). Here’s what to expect:

  1. In the past, was your level of sexual desire or interest good and satisfying to you?
  2. Has there been a decrease in your level of sexual desire or interest?
  3. Are you bothered by your decreased level of sexual desire or interest?
  4. Would you like your level of sexual desire or interest to increase?
  5. Please check any of the factors that you feel may be contributing to your current decrease in sexual desire or interest:

Quick Question

Are you a healthcare professional in the United States?

I AM A HEALTHCARE PROFESSIONAL
I AM NOT A HEALTHCARE PROFESSIONAL
This website is intended for US healthcare professionals only.

Getting back your desire with Vyleesi could be just a few clicks away.

Most eligible patients will pay $0 for their Vyleesi prescription!*

Connect online with a licensed physician to see if Vyleesi is right for you

Let's Go!

You are now leaving Vyleesi.com to go to our telemedicine partner’s site (Prescribery)

Palatin is not affiliated with healthcare providers, does not make any recommendations of specific healthcare providers, and is not responsible for information you share with them. Any prescription is the decision of the healthcare provider alone, based on the patient’s needs. Palatin does not accept any responsibility for the care, treatment, or advice received from any healthcare provider.

*View complete eligibility terms & conditions

Terms & Conditions

‡Depending on your insurance coverage, most eligible patients may pay as little as $0. Each patient’s eligibility is evaluated on an individual basis. Patients must be 18 or older to qualify. These programs and any assistance provided may be discontinued or modified at any time based on eligibility, state and local laws, and program availability. Patients insured by a government-funded program (Medicaid, TRICARE, etc.) are not eligible.

Financial assistance applies to the patient’s copay, coinsurance, or deductible for patients receiving Vyleesi. Palatin contributions against patient deductible and/or out-of-pocket maximums are subject to possible health plan restrictions. Palatin copay assistance will only apply to 2 fills every 30 days. Enrollment into the program cannot be retroactive.